Cotinga Pharmaceuticals Inc COTQF

Healthcare Biotechnology

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

GREY:COTQF - Post by User

Cotinga Pharmaceuticals Inc > Financing done at 11.6 cents pre-consolidation numbers

<< Previous

Bullboard Posts

Next >>

Post by XRRH2008on Sep 20, 2017 10:48am

202 Views

Post# 26719260

Financing done at 11.6 cents pre-consolidation numbers

Pathetic. Embarrasing. This stock just continues to sink to new lows with Allison at the helm.
Seems like the plan all along was to drive down the share price so new blood (including Allison probably) could buy in at much lower price and get more of the company.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec